Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 1/2013

01.01.2013 | Original Article

Impact of smoking on disease phenotype and postoperative outcomes for Crohn’s disease patients undergoing surgery

verfasst von: Myles R. Joyce, Christine D. Hannaway, Scott A. Strong, Victor W. Fazio, Ravi P. Kiran

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Aim

Whether smoking affects disease distribution, phenotype, and perioperative outcomes for Crohn’s disease (CD) patients undergoing surgery is not well characterized. The aim of this study is to evaluate the impact of smoking on disease phenotype and postoperative outcomes for CD patients undergoing surgery

Methods

Prospectively collected data of CD patients undergoing colorectal resection were evaluated. CD patients who were current smokers (CS) were compared to nonsmokers (NS) and ex-smokers (ES) for disease phenotype, anatomic site involved, procedures performed, postoperative outcomes, and quality of life using the Cleveland Global Quality of Life instrument (CGQL).

Results

Of 691 patients with a diagnosis of CD requiring surgery 314 were classified as CS, 330 as NS, and 47 as ES. CS and ES in comparison to NS were significantly older at diagnosis of Crohn’s disease (mean, 29.3 vs. 29.2 vs. 26.3 years) (P = 0.001) and older at the time of primary surgery (mean, 42.9 vs. 48.4 vs. 39 years) (P = 0.001) with a greater frequency of diabetes. In all groups requiring surgery, there was a significant change in disease phenotype from the time of diagnosis to surgical intervention. The predominant phenotype at diagnosis was inflammatory which changed to stricturing and penetrating as the dominant phenotypes at time of surgery. All groups had a significant improvement in CGQL scores post-surgery with the greatest benefit observed in NS. Postoperative complications and 30-day readmission rates were similar between all groups.

Conclusions

The findings of this study show that in patients with CD, disease phenotype changes over time. This occurs independent of smoking. Smoking does not appear to predispose to complications for CD patients undergoing surgery. CS and ES have a persistently reduced quality of life in comparison to NS post-surgery.
Literatur
1.
Zurück zum Zitat Rubin DT, Hanauer SB (2000) Smoking and inflammatory bowel disease. Eur J Gastroenterol Hepatol 12:855–862PubMedCrossRef Rubin DT, Hanauer SB (2000) Smoking and inflammatory bowel disease. Eur J Gastroenterol Hepatol 12:855–862PubMedCrossRef
2.
Zurück zum Zitat Langholz E (2010) Current trends in inflammatory bowel disease. Therap Adv Gastroenterol 3:77–86PubMedCrossRef Langholz E (2010) Current trends in inflammatory bowel disease. Therap Adv Gastroenterol 3:77–86PubMedCrossRef
3.
Zurück zum Zitat Thomas GA, Rhodes J, Green JT, Richardson C (2000) Role of smoking in inflammatory bowel disease: implications for therapy. Postgrad Med J 76:273–279PubMedCrossRef Thomas GA, Rhodes J, Green JT, Richardson C (2000) Role of smoking in inflammatory bowel disease: implications for therapy. Postgrad Med J 76:273–279PubMedCrossRef
4.
Zurück zum Zitat Picco MF, Bayless TM (2003) Tobacco consumption and disease duration are associated with fistulizing and stricturing behaviors in the first 8 years of Crohn’s disease. Am J Gastroenterol 98:363–368PubMedCrossRef Picco MF, Bayless TM (2003) Tobacco consumption and disease duration are associated with fistulizing and stricturing behaviors in the first 8 years of Crohn’s disease. Am J Gastroenterol 98:363–368PubMedCrossRef
5.
Zurück zum Zitat Kane SV, Flicker M, Katz-Nelson F (2005) Tobacco use is associated with accelerated clinical recurrence of Crohn’s disease after surgically induced remission. J Clin Gastroenterol 39:32–35PubMed Kane SV, Flicker M, Katz-Nelson F (2005) Tobacco use is associated with accelerated clinical recurrence of Crohn’s disease after surgically induced remission. J Clin Gastroenterol 39:32–35PubMed
6.
Zurück zum Zitat Moller AM, Villebro N, Pedersen T, Tonnesen H (2002) Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial. Lancet 359:114–117PubMedCrossRef Moller AM, Villebro N, Pedersen T, Tonnesen H (2002) Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial. Lancet 359:114–117PubMedCrossRef
7.
Zurück zum Zitat Yamamoto T (2005) Factors affecting recurrence after surgery for Crohn’s disease. World J Gastroenterol 11:3971–3979PubMed Yamamoto T (2005) Factors affecting recurrence after surgery for Crohn’s disease. World J Gastroenterol 11:3971–3979PubMed
8.
Zurück zum Zitat Delgado-Rodriguez M, Medina-Cuadros M, Martinez-Gallego G et al (2003) A prospective study of tobacco smoking as a predictor of complications in general surgery. Infect Control Hosp Epidemiol 24:37–43PubMedCrossRef Delgado-Rodriguez M, Medina-Cuadros M, Martinez-Gallego G et al (2003) A prospective study of tobacco smoking as a predictor of complications in general surgery. Infect Control Hosp Epidemiol 24:37–43PubMedCrossRef
9.
Zurück zum Zitat Finan KR, Vick CC, Kiefe CI, Neumayer L, Hawn MT (2005) Predictors of wound infection in ventral hernia repair. Am J Surg 190:676–681PubMedCrossRef Finan KR, Vick CC, Kiefe CI, Neumayer L, Hawn MT (2005) Predictors of wound infection in ventral hernia repair. Am J Surg 190:676–681PubMedCrossRef
10.
Zurück zum Zitat Kiran RP, Delaney CP, Senagore AJ et al (2003) Prospective assessment of Cleveland Global Quality of Life and disease activity in Crohn’s disease. Am J Gastroenterol 98:1783–1789PubMedCrossRef Kiran RP, Delaney CP, Senagore AJ et al (2003) Prospective assessment of Cleveland Global Quality of Life and disease activity in Crohn’s disease. Am J Gastroenterol 98:1783–1789PubMedCrossRef
11.
Zurück zum Zitat Fazio VW, O’Riordain MG, Lavery IC et al (1999) Long-term functional outcome and quality of life after stapled restorative proctocolectomy. Ann Surg 230:575–586PubMedCrossRef Fazio VW, O’Riordain MG, Lavery IC et al (1999) Long-term functional outcome and quality of life after stapled restorative proctocolectomy. Ann Surg 230:575–586PubMedCrossRef
12.
Zurück zum Zitat Sorensen LT, Karlsmark T, Gottrup F (2003) Abstinence from smoking reduces incisional wound infection: a randomized controlled trial. Ann Surg 238:1–5PubMed Sorensen LT, Karlsmark T, Gottrup F (2003) Abstinence from smoking reduces incisional wound infection: a randomized controlled trial. Ann Surg 238:1–5PubMed
13.
Zurück zum Zitat Moller A, Tonnesen H (2006) Risk reduction: perioperative smoking intervention. Best Pract Res Clin Anaesthesiol 20:237–248PubMedCrossRef Moller A, Tonnesen H (2006) Risk reduction: perioperative smoking intervention. Best Pract Res Clin Anaesthesiol 20:237–248PubMedCrossRef
14.
Zurück zum Zitat Theadom A, Cropley M (2006) Effects of preoperative smoking cessation on the incidence and risk of intraoperative and postoperative complications in adult smokers: a systematic review. Tob Control 15:352–358PubMedCrossRef Theadom A, Cropley M (2006) Effects of preoperative smoking cessation on the incidence and risk of intraoperative and postoperative complications in adult smokers: a systematic review. Tob Control 15:352–358PubMedCrossRef
15.
Zurück zum Zitat Avidan B, Sakhnini E, Lahat A et al (2005) Risk factors regarding the need for a second operation in patients with Crohn’s disease. Digestion 72:248–253PubMedCrossRef Avidan B, Sakhnini E, Lahat A et al (2005) Risk factors regarding the need for a second operation in patients with Crohn’s disease. Digestion 72:248–253PubMedCrossRef
16.
Zurück zum Zitat Lindeberg E, Jarnerot G, Huitfeldt (1992) Smoking in Crohn’s disease:effect on localization and clinical course. Gut 33:779–782CrossRef Lindeberg E, Jarnerot G, Huitfeldt (1992) Smoking in Crohn’s disease:effect on localization and clinical course. Gut 33:779–782CrossRef
17.
Zurück zum Zitat Yamamoto T, Kneighley RB (1999) The association of cigarette smoking with a high risk of recurrence after ileocolic resection for ileocecal Crohn’s disease. Surg Today 29:579–580PubMedCrossRef Yamamoto T, Kneighley RB (1999) The association of cigarette smoking with a high risk of recurrence after ileocolic resection for ileocecal Crohn’s disease. Surg Today 29:579–580PubMedCrossRef
18.
Zurück zum Zitat Ford AC, Sandbom WJ, Khan KJ et al (2011) Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol 106:644–659PubMedCrossRef Ford AC, Sandbom WJ, Khan KJ et al (2011) Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol 106:644–659PubMedCrossRef
19.
Zurück zum Zitat Canavan C, Abrams KR, Mayberry JF (2007) Meta-analysis: mortality in Crohn’s disease. Aliment Pharmacol Ther 25:861–870PubMedCrossRef Canavan C, Abrams KR, Mayberry JF (2007) Meta-analysis: mortality in Crohn’s disease. Aliment Pharmacol Ther 25:861–870PubMedCrossRef
20.
Zurück zum Zitat Lakatos PL, Czegledi Z, Szamosi T et al (2009) Perianal disease, small bowel disease, smoking, prior steroid or azathioprine/biological therapy are predictors of disease change in patients with Crohn’s disease. World J Gastroenterol 15:3505–3510 Lakatos PL, Czegledi Z, Szamosi T et al (2009) Perianal disease, small bowel disease, smoking, prior steroid or azathioprine/biological therapy are predictors of disease change in patients with Crohn’s disease. World J Gastroenterol 15:3505–3510
21.
Zurück zum Zitat Louis E, Collard A, Oger AF et al (2001) Behaviour of Crohn’s disease according to the Vienna classification: changing pattern over the course of the disease. Gut 49:777–782PubMedCrossRef Louis E, Collard A, Oger AF et al (2001) Behaviour of Crohn’s disease according to the Vienna classification: changing pattern over the course of the disease. Gut 49:777–782PubMedCrossRef
22.
Zurück zum Zitat Chow DK, Leong RW, Lai LH et al (2008) Changes in Crohn’s disease phenotype over time in the Chinese population: validation of the Montreal classification system. Inflamm Bowel Dis 14:536–541PubMedCrossRef Chow DK, Leong RW, Lai LH et al (2008) Changes in Crohn’s disease phenotype over time in the Chinese population: validation of the Montreal classification system. Inflamm Bowel Dis 14:536–541PubMedCrossRef
23.
Zurück zum Zitat Hongyan C, Alexander L, Bowcock A et al (2011) Influence of Crohn’s disease risk alleles and smoking on disease location. Dis Colon Rectum 54:1020–1025CrossRef Hongyan C, Alexander L, Bowcock A et al (2011) Influence of Crohn’s disease risk alleles and smoking on disease location. Dis Colon Rectum 54:1020–1025CrossRef
24.
Zurück zum Zitat Tamas S, Janos B, Lakatos L et al (2010) Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays to time to surgery but not reoperation in both smokers and nonsmokers with Crohn’s disease, while smoking decreases the risk of colectomy in ulcerative colitis. Eur J Gastroenterol Hepatol 22:872–879CrossRef Tamas S, Janos B, Lakatos L et al (2010) Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays to time to surgery but not reoperation in both smokers and nonsmokers with Crohn’s disease, while smoking decreases the risk of colectomy in ulcerative colitis. Eur J Gastroenterol Hepatol 22:872–879CrossRef
25.
Zurück zum Zitat Sunyoung P, Do-Hoon L, Jae-Gahb P, Young T (2010) A sensitive enzyme immunoassay for measuring cotinine in passive smokers. Clinica Chimica Acta 411:1238–1242CrossRef Sunyoung P, Do-Hoon L, Jae-Gahb P, Young T (2010) A sensitive enzyme immunoassay for measuring cotinine in passive smokers. Clinica Chimica Acta 411:1238–1242CrossRef
Metadaten
Titel
Impact of smoking on disease phenotype and postoperative outcomes for Crohn’s disease patients undergoing surgery
verfasst von
Myles R. Joyce
Christine D. Hannaway
Scott A. Strong
Victor W. Fazio
Ravi P. Kiran
Publikationsdatum
01.01.2013
Verlag
Springer-Verlag
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 1/2013
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-011-0865-9

Weitere Artikel der Ausgabe 1/2013

Langenbeck's Archives of Surgery 1/2013 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.